A normal ECG at birth does not exclude significant congenital cardiac conduction disease associated with maternal anti-Ro antibodies [1]

Rheumatology

Volumn 40, Issue 8, 2001, Pages 939-940

  Gordon, P A ^a   Khamashta, M A ^a   Hughes, G R V ^a   Rosenthal, E ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CESAREAN SECTION; COMPLETE HEART BLOCK; CONGENITAL HEART BLOCK; ELECTROCARDIOGRAM; FEMALE; FETUS HEART RATE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; KERATOCONJUNCTIVITIS SICCA; LETTER; PREGNANCY; PRIORITY JOURNAL; PROGENY; SJOEGREN SYNDROME; ULTRASOUND;

EID: 0034868569     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.8.939     Document Type: Letter

References (6)

1. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry
2. Congenital heart block risk to newborns of mothers with anti-Ro/SSA antibodies. A prospective study of 105 pregnancies
3. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital complete heart block
4. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and fantibodies
5. Monozygotic twins discordant for congenital heart block
6. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block: Retrospective review of the research registry for neonatal lupus